EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,874,659 | -10.5% | 1,736,503 | -2.6% | 0.03% | -8.8% |
| Q2 2023 | $15,505,592 | +170.5% | 1,782,252 | -8.6% | 0.03% | +161.5% |
| Q1 2023 | $5,733,000 | -16.0% | 1,950,000 | 0.0% | 0.01% | -18.8% |
| Q4 2022 | $6,825,000 | -55.8% | 1,950,000 | 0.0% | 0.02% | -57.9% |
| Q3 2022 | $15,425,000 | +0.5% | 1,950,000 | 0.0% | 0.04% | +8.6% |
| Q2 2022 | $15,347,000 | -35.2% | 1,950,000 | 0.0% | 0.04% | -22.2% |
| Q1 2022 | $23,693,000 | -0.7% | 1,950,000 | 0.0% | 0.04% | +4.7% |
| Q4 2021 | $23,868,000 | +29.9% | 1,950,000 | +10.6% | 0.04% | +19.4% |
| Q3 2021 | $18,371,000 | +27.7% | 1,763,031 | +10.2% | 0.04% | +28.6% |
| Q2 2021 | $14,384,000 | -6.7% | 1,600,000 | +5.4% | 0.03% | -9.7% |
| Q1 2021 | $15,425,000 | – | 1,518,211 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |